Drug Trial Radar · NCT05289661
Descemet Endothelial Thickness Comparison Trial I
Last checked: Nov 19, 2026Latest source record: Nov 6, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
160
Actual
Start
Jul 15, 2022
Primary completion
Nov 30, 2026
Study completion Nov 30, 2027
Sponsor
- Lead sponsor
- Stanford UniversityAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Oregon Health and Science University; University of California, San Francisco; University of California, Davis; Case Western Reserve University; Dartmouth-Hitchcock Medical Center; University of Pennsylvania; University of Miami; Wills Eye Hospital
- First posted
- Mar 21, 2022
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Factorial
- Masking
- Triple (participant, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Descemet Endothelial Thickness Comparison Trial (DETECT) I is a multi-center, outcome assessor-masked, placebo-controlled clinical trial randomizing 160 patients in a 2x2 factorial design. The purpose of this study is to determine differences in visual outcomes between two types of corneal transplant surgeries, ultrathin Descemet stripping automated endothelial keratoplasty (UT-DSAEK) and Descemet membrane endothelial keratoplasty (DMEK), and to determine the effect of rho-kinase inhibitors on endothelial cell loss.
Conditions
- Fuchs
Interventions
Topical RipasudilDrug
To determine the effect of rho-kinase inhibitors on endothelial cell loss
Topical PlaceboDrug
topical Placebo
Primary outcomes
What the sponsor says the trial is designed to measure.
- Best spectacle-corrected visual acuity (BSCVA)Time frame: 12 months
- Endothelial cell lossTime frame: 12 months
Locations
7 sites in 1 country. Site status is shown where the registry gives one.
Stanford University
Palo Alto, California
University of California Davis
Sacramento, California
University of Miami
Palm Beach Gardens, Florida
Dartmouth-Hitchcock Medical Center
Lebanon, New Hampshire
Oregon Health & Science University
Portland, Oregon
University of Pennsylvania
Philadelphia, Pennsylvania
Wills Eye Hospital
Philadelphia, Pennsylvania
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.